JP2006517532A5 - - Google Patents

Download PDF

Info

Publication number
JP2006517532A5
JP2006517532A5 JP2006500216A JP2006500216A JP2006517532A5 JP 2006517532 A5 JP2006517532 A5 JP 2006517532A5 JP 2006500216 A JP2006500216 A JP 2006500216A JP 2006500216 A JP2006500216 A JP 2006500216A JP 2006517532 A5 JP2006517532 A5 JP 2006517532A5
Authority
JP
Japan
Prior art keywords
alkyl
independently
aryl
compound according
ipr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006500216A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006517532A (ja
JP4612621B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2004/000147 external-priority patent/WO2004065354A1/en
Publication of JP2006517532A publication Critical patent/JP2006517532A/ja
Publication of JP2006517532A5 publication Critical patent/JP2006517532A5/ja
Application granted granted Critical
Publication of JP4612621B2 publication Critical patent/JP4612621B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006500216A 2003-01-17 2004-01-19 Hdac阻害剤としてのエステル又はケトン結合を含むカルバミン酸化合物 Expired - Fee Related JP4612621B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44061603P 2003-01-17 2003-01-17
PCT/GB2004/000147 WO2004065354A1 (en) 2003-01-17 2004-01-19 Carbamic acid compounds comprising an ester or ketone linkage as hdac inhibitors

Publications (3)

Publication Number Publication Date
JP2006517532A JP2006517532A (ja) 2006-07-27
JP2006517532A5 true JP2006517532A5 (cg-RX-API-DMAC7.html) 2010-10-21
JP4612621B2 JP4612621B2 (ja) 2011-01-12

Family

ID=32771842

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006500216A Expired - Fee Related JP4612621B2 (ja) 2003-01-17 2004-01-19 Hdac阻害剤としてのエステル又はケトン結合を含むカルバミン酸化合物

Country Status (6)

Country Link
US (1) US7465719B2 (cg-RX-API-DMAC7.html)
EP (1) EP1583736A1 (cg-RX-API-DMAC7.html)
JP (1) JP4612621B2 (cg-RX-API-DMAC7.html)
AU (1) AU2004205372B2 (cg-RX-API-DMAC7.html)
CA (1) CA2513246A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004065354A1 (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003076401A1 (en) 2002-03-13 2003-09-18 Janssen Pharmaceutica N.V. Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
CA2476583C (en) 2002-03-13 2011-07-05 Kristof Van Emelen Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
JP4648628B2 (ja) 2002-03-13 2011-03-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒストンデアセチラーゼの新規な阻害剤としてのカルボニルアミノ誘導体
CN100396679C (zh) 2002-03-13 2008-06-25 詹森药业有限公司 用作组蛋白脱乙酰化酶抑制剂的哌嗪基、哌啶基和吗啉基衍生物
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7250514B1 (en) 2002-10-21 2007-07-31 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7375228B2 (en) 2003-03-17 2008-05-20 Takeda San Diego, Inc. Histone deacetylase inhibitors
HRP20120327T1 (hr) 2004-07-28 2012-05-31 Janssen Pharmaceutica Nv Supstituirani indolil alkil amino derivati kao novi inhibitori histonske deacetilaze
US7642275B2 (en) 2004-12-16 2010-01-05 Takeda San Diego, Inc. Histone deacetylase inhibitors
JP2008540574A (ja) 2005-05-11 2008-11-20 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
DK1885710T3 (en) 2005-05-18 2015-11-23 Janssen Pharmaceutica Nv SUBSTITUTED AMINOPROPENYLPIPERIDINE OR MORPHOLINE DERIVATIVES AS UNKNOWN INHIBITORS OF HISTONDEACETYLASE
CA2615105A1 (en) 2005-07-14 2007-01-25 Takeda San Diego, Inc. Histone deacetylase inhibitors
CA2623360C (en) 2005-10-27 2014-04-22 Janssen Pharmaceutica N.V. Squaric acid derivatives as inhibitors of histone deacetylase
KR100696139B1 (ko) * 2005-11-01 2007-03-20 한국화학연구원 히스톤 디아세틸라제 저해활성을 갖는 알킬카바모일나프탈렌일옥시 옥테노일 하이드록시아마이드 유도체 및그의 제조방법
DK1981875T3 (da) 2006-01-19 2014-07-14 Janssen Pharmaceutica Nv Substituerede indolylalkylaminoderivater som inhibitorer af histondeacetylase
EP1979326B1 (en) 2006-01-19 2012-10-03 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
EP1979327A1 (en) 2006-01-19 2008-10-15 Janssen Pharmaceutica, N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
ES2327972T3 (es) 2006-01-19 2009-11-05 Janssen Pharmaceutica, N.V. Derivados de aminofenil como nuevos inhibidores de histona deacetilasa.
JP5277171B2 (ja) * 2006-11-03 2013-08-28 コリア リサーチ インスティテュート オブ ケミカル テクノロジーズ ヒストン脱アセチル化酵素阻害活性を有するナフタレニルオキシプロペニル誘導体およびこれを含む薬学組成物
JP2010513326A (ja) * 2006-12-19 2010-04-30 メシルジーン インコーポレイテッド ヒストンデアセチラーゼの阻害薬及びそのプロドラッグ
US8012972B2 (en) 2007-03-28 2011-09-06 Santen Pharmaceutical Co., Ltd. Pyridinecarboxylic acid (2-aminophenyl) amide derivative having urea structure
WO2008123395A1 (ja) 2007-03-28 2008-10-16 Santen Pharmaceutical Co., Ltd. ヒストン脱アセチル化酵素阻害作用を有する化合物を有効成分として含有する眼圧下降剤
US8293513B2 (en) * 2007-12-14 2012-10-23 Georgetown University Histone deacetylase inhibitors
WO2009086277A1 (en) 2007-12-20 2009-07-09 Envivo Pharmaceuticals, Inc. Tetrasubstituted benzenes
US8198271B2 (en) * 2008-05-23 2012-06-12 Santen Pharmaceutical Co., Ltd. Thiophenediamine derivative having urea structure
US10357493B2 (en) 2017-03-10 2019-07-23 Selenity Therapeutics (Bermuda), Ltd. Metalloenzyme inhibitor compounds
CN114727974A (zh) 2019-07-30 2022-07-08 艾科尼佐治疗股份有限公司 Hdac6抑制剂及其用途
WO2022169985A1 (en) 2021-02-03 2022-08-11 Eikonizo Therapeutics, Inc. Hdac6 inhibitors and uses thereof
AU2023250964A1 (en) 2022-04-08 2024-11-07 Eikonizo Therapeutics, Inc. Oxadiazole hdac6 inhibitors and uses thereof
US12553903B2 (en) 2023-06-01 2026-02-17 Cg Pharmaceuticals, Inc Ivaltinostat combination therapy for treating pancreatic cancer

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS532852B2 (cg-RX-API-DMAC7.html) 1972-04-25 1978-02-01
JPS5777646A (en) 1980-10-31 1982-05-15 Kanto Kagaku Kk Preparation of hydroxamic acid
JPH04217950A (ja) 1990-03-28 1992-08-07 Asahi Chem Ind Co Ltd ヒドロキサム酸誘導体および酵素阻害剤ならびに抗潰瘍剤
US5318964A (en) 1992-06-11 1994-06-07 Hoffmann-La Roche Inc. Hydroxamic derivatives and pharmaceutical compositions
JPH0775593A (ja) 1993-09-08 1995-03-20 Suntory Ltd 蛋白質の製造方法
GB9501737D0 (en) 1994-04-25 1995-03-22 Hoffmann La Roche Hydroxamic acid derivatives
EP0827742A1 (en) 1996-09-04 1998-03-11 Vrije Universiteit Brussel Use of histone deacetylase inhibitors for treating fribosis or cirrhosis
US7115632B1 (en) 1999-05-12 2006-10-03 G. D. Searle & Co. Sulfonyl aryl or heteroaryl hydroxamic acid compounds
CA2265671A1 (en) 1997-07-10 1999-01-21 Daniela Jabes Matrix metalloproteinase inhibitors
WO1999024399A1 (en) 1997-11-12 1999-05-20 Darwin Discovery Limited Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
US6479502B1 (en) 1998-08-29 2002-11-12 British Biotech Pharmaceuticals Hydroxamic acid derivatives as proteinase inhibitors
GB9919776D0 (en) 1998-08-31 1999-10-27 Zeneca Ltd Compoujnds
DE19858548A1 (de) 1998-12-18 2000-06-21 Schlafhorst & Co W Fadenführer zum traversierenden Zuführen eines Fadens zu einer rotierend angetriebenen Auflaufspule
AU775701B2 (en) 1999-02-08 2004-08-12 G.D. Searle & Co. Sulfamato hydroxamic acid metalloprotease inhibitor
JP2003525203A (ja) 1999-03-22 2003-08-26 ダーウィン・ディスカバリー・リミテッド ヒドロキサムおよびカルボン酸誘導体
EP1165500A1 (en) * 1999-04-02 2002-01-02 Du Pont Pharmaceuticals Company Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase
WO2000069819A1 (en) 1999-05-12 2000-11-23 G.D. Searle & Co. Hydroxamic acid derivatives as matrix metalloprotease inhibitors
GB9911073D0 (en) 1999-05-12 1999-07-14 Darwin Discovery Ltd Hydroxamic and carboxylic acid derivatives
TR200200360T2 (tr) 1999-08-10 2002-06-21 British Biotech Pharmaceuticals Limited Antibakteriyel aktif maddeler.
KR20100035666A (ko) 1999-11-23 2010-04-05 메틸진 인크. 히스톤 디아세틸라제의 억제제
GB9929979D0 (en) 1999-12-17 2000-02-09 Darwin Discovery Ltd Hydroxamic acid derivatives
EP1261595A1 (en) 2000-02-21 2002-12-04 AstraZeneca AB Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents
JP2003528074A (ja) * 2000-03-24 2003-09-24 メチルジーン インコーポレイテッド ヒストン脱アセチル化酵素の阻害剤
EP1282614B1 (en) 2000-05-15 2003-11-12 Darwin Discovery Limited Hydroxamic acid derivatives
PE20020354A1 (es) 2000-09-01 2002-06-12 Novartis Ag Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
WO2002028829A2 (en) 2000-09-25 2002-04-11 Questcor Pharmaceuticals, Inc. Peptide deformylase inhibitors
CA2423868C (en) 2000-09-29 2011-06-07 Prolifix Limited Carbamic acid compounds comprising an amide linkage as hdac inhibitors
GB0023983D0 (en) 2000-09-29 2000-11-15 Prolifix Ltd Therapeutic compounds
EP2292593A3 (en) 2000-09-29 2011-05-25 TopoTarget UK Limited Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
WO2002074298A1 (en) * 2001-03-21 2002-09-26 Ono Pharmaceutical Co., Ltd. Il-6 production inhibitors

Similar Documents

Publication Publication Date Title
JP2005527556A5 (cg-RX-API-DMAC7.html)
RU2324687C2 (ru) Производные бензотиазола, характеризующиеся агонистической активностью к бета-2-адренорецепторам
RU2391346C2 (ru) 39-дезметокси производные рапамицина
RU2477723C2 (ru) Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
JP2019518766A5 (cg-RX-API-DMAC7.html)
JP2003532731A5 (cg-RX-API-DMAC7.html)
RU2015107803A (ru) Производные дигидроксипиримидинкарбоновой кислоты и их применение в лечении, облегчении или предотвращении вирусного заболевания
JP2004511462A5 (cg-RX-API-DMAC7.html)
RU2015142102A (ru) Соединение для лечения рака
JP2010530881A5 (cg-RX-API-DMAC7.html)
JP2012500260A5 (cg-RX-API-DMAC7.html)
JP2007502806A5 (cg-RX-API-DMAC7.html)
JP2019500315A5 (cg-RX-API-DMAC7.html)
RU2015154955A (ru) Производные бензотиофенов в качестве ингибиторов рецептора эстрогенов
RU2006129312A (ru) Производные ариланилина в качестве агонистов 2 адренергического рецептора
JP2010503688A5 (cg-RX-API-DMAC7.html)
JP2013533253A5 (cg-RX-API-DMAC7.html)
JP2018529770A5 (cg-RX-API-DMAC7.html)
RU2000127751A (ru) Противоопухолевое средство
JP2002030084A5 (cg-RX-API-DMAC7.html)
JP2011509302A5 (cg-RX-API-DMAC7.html)
JP2017509694A5 (cg-RX-API-DMAC7.html)
JP2013522368A5 (cg-RX-API-DMAC7.html)
JP2019534865A5 (cg-RX-API-DMAC7.html)
JPH11512422A (ja) ベンゾチアゾロン誘導体